相关实验视频
Updated: Jul 13, 2026

10:42
A Tripeptide-Stabilized Nanoemulsion of Oleic Acid
Published on: February 27, 2019
9.4K
稳定精油:基于多糖类的药物输送系统,具有基于生物仿真概念的类似植物结构
Xue-Yee Lim1, Jing Li1, Hong-Mei Yin2
1School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
Polymers
|August 26, 2023
概括
基于多糖的仿生药物输送系统通过模仿植物结构,有效地稳定了精油 (EO). 这些系统提供了对降解的保护,提高了EO的稳定性和应用潜力.
科学领域:
- 制药科学 制药科学
- 材料科学 材料科学 材料科学
- 自然产品化学 自然产品化学
背景情况:
- 由于挥发性,氧化和对环境因素的敏感性,精油容易降解.
- 药物输送系统,特别是聚合物载体,可以提高EO的稳定性.
- 多糖是药物载体的理想候选者,因为它们的安全性,多功能性和丰富性.
研究的目的:
- 探索基于多糖的生物模拟药物输送系统,以稳定精油 (EO).
- 为了加强保护,将EO输送系统与植物组织结构联系起来.
- 审查各种多糖类作为EO保护载体的特性和应用.
主要方法:
- 文献综述侧重于EO的多糖基药物载体.
- 分析EO传递系统中的仿生概念.
- 关于特定多糖的研究总结 (阿拉伯,粉,纤维素,奇托,藻酸盐,点,普鲁兰) 和它们的改性形式.
主要成果:
- 基于多糖的系统通过模仿天然植物结构来有效地稳定EO.
- 各种多糖类,包括阿拉伯糖,粉和奇托,显示出具有重要的EO保护潜力.
- 改性多糖提供了定制的特性,以改善EO封装和稳定性.
结论:
- 生物仿真多糖类药物输送系统是稳定精油的有希望的策略.
- 多糖的固有特性使得它们成为开发先进的EO配方的优秀候选者.
- 对改性多糖的进一步研究可以为稳定的EO开启新的应用.
相关概念视频
Bioavailability Enhancement: Drug Permeability Enhancement
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Oral Drug Delivery Systems: Delayed-Release Systems
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...

